<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">Cerebral vasospasm</z:e> is a deadly complication following the rupture of <z:hpo ids='HP_0004944'>intracranial aneurysms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The time course of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> is unique in that it is slow developing, usually takes 4-7 days to peak, but lasts up to 2-3 weeks, and is resistant to most known <z:chebi fb="1" ids="35620">vasodilators</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>These special features make <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> the most important determinant in the outcome of patients suffering <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The available treatment strategies include mechanical dilation of spastic cerebral arteries (angioplasty) and non-selective vasodilatation such as by Ca(2+) channel blockers </plain></SENT>
<SENT sid="4" pm="."><plain>One new development in the experimental treatment of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> is the looming target of signaling pathways </plain></SENT>
<SENT sid="5" pm="."><plain>Understanding vasospastic signals in cerebral arteries might offer a new avenue for selective treatment of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> in the future </plain></SENT>
</text></document>